Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient Perspectives on Health-Related Quality of Life in Diffuse Large B-Cell Lymphoma Treated with Car T-Cell Therapy: A Qualitative Study
Authors
Keywords
-
Journal
Oncology and Therapy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-11-15
DOI
10.1007/s40487-021-00174-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life
- (2020) Surbhi Sidana et al. BLOOD
- Health-related quality of life (HRQOL) burden in patients with relapsed/refractory diffuse large B-cell lymphoma (RR-DLBCL) and non-Hodgkin’s lymphoma (RR-NHL).
- (2020) Vincent Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis
- (2019) Emma J.M. Grigor et al. TRANSFUSION MEDICINE REVIEWS
- Diffuse Large B cell Lymphoma: 2019 update on diagnosis, risk-stratification and treatment
- (2019) Yang Liu et al. AMERICAN JOURNAL OF HEMATOLOGY
- Patient-reported disease burden in chronic lymphocytic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma: Results from a national patient advocacy survey.
- (2019) Mark Price et al. JOURNAL OF CLINICAL ONCOLOGY
- PROMIS® Adult Health Profiles: Efficient Short-Form Measures of Seven Health Domains
- (2019) David Cella et al. VALUE IN HEALTH
- NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019
- (2019) Andrew D. Zelenetz et al. Journal of the National Comprehensive Cancer Network
- Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology
- (2019) Rahma Warsame et al. MAYO CLINIC PROCEEDINGS
- Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy
- (2019) Julia Ruark et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients
- (2018) Kareem Jamani et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Harnessing the Power of Patient-Reported Outcomes in Oncology
- (2018) Ryan D. Nipp et al. CLINICAL CANCER RESEARCH
- Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
- (2018) Thomas A. Ollila et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma
- (2018) Carrie A. Thompson et al. HEMATOLOGICAL ONCOLOGY
- PROMIS®-29 v2.0 profile physical and mental health summary scores
- (2018) Ron D. Hays et al. QUALITY OF LIFE RESEARCH
- Patient-Reported Outcomes with Chimeric Antigen Receptor T Cell Therapy: Challenges and Opportunities
- (2018) Rajshekhar Chakraborty et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
- (2017) Lonneke van de Poll-Franse et al. QUALITY OF LIFE RESEARCH
- Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma
- (2017) Annalisa Chiappella et al. Expert Review of Hematology
- Living with a rare disorder: a systematic review of the qualitative literature
- (2017) Charlotte von der Lippe et al. Molecular Genetics & Genomic Medicine
- 2016 US lymphoid malignancy statistics by World Health Organization subtypes
- (2016) Lauren R. Teras et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014)
- (2016) Ari Gnanasakthy et al. JOURNAL OF CLINICAL ONCOLOGY
- Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments
- (2016) Matthias Schwenkglenks et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) H. Tilly et al. ANNALS OF ONCOLOGY
- Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era
- (2013) Sarah J. Nagle et al. AMERICAN JOURNAL OF HEMATOLOGY
- Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry
- (2013) M. W. M. van der Poel et al. ANNALS OF HEMATOLOGY
- A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy – Lymphoma Symptom Index
- (2013) Fay J. Hlubocky et al. LEUKEMIA & LYMPHOMA
- Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors
- (2011) David Telio et al. LEUKEMIA & LYMPHOMA
- Quality of life in patients with diffuse large B-cell lymphoma treated with dose-dense chemotherapy is only affected temporarily
- (2011) Dorte Tholstrup et al. LEUKEMIA & LYMPHOMA
- Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- (2011) J. W. Friedberg Hematology-American Society of Hematology Education Program
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
- (2010) David Cella et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- PRO development: rigorous qualitative research as the crucial foundation
- (2010) Kathryn Eilene Lasch et al. QUALITY OF LIFE RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now